Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- TVVSN MurthyDesignation :- Director Shareholding for the Period Ended June 30, 2018
SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Receipt Of Establishment Inspection Report From US FDA.
Receipt of Establishment Inspection Report from US FDA. Board to consider Dividend
SMS Lifesciences India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on May 28, 2018, inter alia, to consider the following items:1. To consider and approve the Financial Results for Quarter ended on March 31, 2018.2. To consider and approve the Annual Audited Financial Statements for the financial year ended on March 31, 2018.... Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- VEERA VENKATA SATYANARAYANA MURTHYDesignation :- Director Compliance Certificate Under Regulation 7(3) Of SEBI(LODR)Regulations,2015.
Compliance Certificate under Regulation 7(3) of SEBI(LODR)Regulations,2015.